Answers are grounded in this paper and cite their sources.
In order to compare the age-specific incidence rates of stomach cancer between Japan and other countries, we extracted cancer incidence rates from the Cancer Incidence in Five Continents Vol. XI (CI5) (1). The International Agency for Research on Cancer provides the CI5 databases on the incidence of cancer recorded in cancer registries (regional and national) worldwide. We used the cancer incidence rates in five countries in Asia (China, India, Japan, Republic of Korea and Thailand), three countries in America (the USA, Canada and Brazil), two countries in Oceania (Australia and New Zealand) and four countries in Europe (the UK, France, Germany and Italy). Some countries have multiple cancer registries, and we aggregated all of the registries to calculate the incidence rates in the countries from the CI5-XI database. The year of cancer diagnosis was set to between 2008 and 2012. Stomach cancer was coded as C16 based on ICD-10. Age-specific cancer incidence rates in males by countries studied are shown in Fig. 1. In Asia, there was a larger variance in incidence between countries compared with other regions. China, Japan and the Republic of Korea (South Korea) had a higher incidence compared with other Asian regions. In contrast, the overall incidence for India and Thailand tended to be lower than the incidences in the Americas, Oceania and Europe. Among countries in the Americas and Oceania, Brazil had a higher incidence compared with other countries, while others tended to have a lower incidence than Europe. Within Europe, Germany and Italy tended to have higher incidences than the United Kingdom and France. However, there was a lower variance in incidence between countries in Europe. The incidence in the younger age group (<39 years old) was below 10 (per 100 000) in all regions with the exception of South Korea. For East Asia, the incidence began to increase in the younger age groups compared with other regions. There was a steep increase in incidence with older age in all regions except China and South Korea. In Japan, the incidence in 85+ year olds exceeded 700 (per 100 000). The incidence in China and South Korea peaked at ages 80–84 and 75–79 years, respectively, and declined thereafter. The peak incidence in China and South Korea was approximately 250 (per 100 000) and 530 (per 100 000), respectively. As for the Americas and Oceania, the incidence in Brazil was approximately 160 (per 100 000) in the 80+ age group whereas the incidences in the other countries in this group ranged from 65 to 105 (per 100 000) in 85+ year olds. In addition the incidence in 85+ year olds ranged from 100 to 200 (per 100 000) in Europe.
No takes yet. Share an insight, caveat, or question.
Hori et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: